AMWC Dubai 2025, Booth C-78

Dubai from 1,2,3 October 2025.

PRP is more than a trend — it is evidence-based regenerative medicine.

We are pleased to announce that Regen Lab will be exhibiting at AMWC Dubai 2025, taking place from 1 to 3 October at the Grand Hyatt Dubai.

Visit us at Stand C-78 to discover our latest innovations in regenerative medicine for aesthetics and dermatology.

  • Gain insights into breakthrough regenerative solutions
  • Explore how synergistic PRP combinations are redefining results in surgery and aesthetics.
  • Connect with experts at the forefront of innovation

Regen Lab activities

Symposium

Exclusive AMWC Dubai Symposium – October 3rd, 2025

16:30–17:30 Al Ameera Ballroom 2

HA and Platelet-Gel combined with RegenPRP™ ; learn the benefits of these exclusive technologies.

Dr Jamila Atannaz

Aesthetic & Plastic Surgeon – Morocco

“Use of platelet gel in surgery for infection prevention and wound healing”

Dr Jamila Atannaz is a specialist in plastic, aesthetic, reconstructive, and burn surgery. Passionate about helping patients feel comfortable in their bodies, she offers treatments in aesthetic medicine, cosmetic surgery, and reconstructive procedures. 

Dr. Bruce Reith

Head of department – Germany

“Why PRP-HA combination is interesting for alopecia”

Completed his surgical trainings at the university hospitals in Munich. He pursued further education as a fellow in plastic surgery under the guidance of Prof. Ivo Pitanguy in Rio de Janeiro. He has specialized in hair surgery and has performed over 10,000 procedures.

About Us

Since 2003, Regen Lab SA has specialized in designing and manufacturing high-quality medical devices for cell therapies and the preparation of autologous platelet-rich plasma (PRP) from the patient's own blood for bedside procedures.

Milestones

2003 - Foundation
2010 - RegenKit first approval in bone graft
2013 - A new state-of-theart laboratory in Lausanne
2014 - Cellular Matrix first approval
2015 - Launch of Cellular Matrix in Europe

Vision

Founded in 2003, Regen Lab has become a global reference thanks to its commitment to innovation, quality, and the effectiveness of its therapeutic solutions. Here’s how we have transformed the medical landscape over the past two decades.

RegenPRP™

RegenPRP™ is a medical treatment that uses platelet-rich plasma from the patient's own blood to enhance and tissue regeneration.

RegenPRP™ - HA

RegenPRP™ - HA combination is an innovative treatment combining platelet-rich plasma (PRP) and hyaluronic acid to improve tissue regeneration and healing.

RegenPRP™ - ATS

RegenPRP™ combined with ATS (Autologous Thrombin Serum) is an advanced approach to tissue regeneration that uses autologous thrombin-enriched platelet-rich plasma (PRP) to maximise healing effects.

RegenExtracell®

RegenExtracell is an innovative tissue regeneration treatment using an extracellular matrix enriched with platelet-rich plasma (PRP).

Hyaluronic Acid

Coming Soon

Regulatory

Manufacturers of medical devices based outside the EU must designate an Authorized Representative (EC-REP) established within the EU in order to meet the CE requirements for placing medical devices on the EU market.

Quality Management

Regen Lab Quality System Management ensures the consistency of our products quality in total GMP compliance.

Our production facility rooms atmosphere is monitored to satisfy non-pyrogenic medical devices manufacturing.

Patents

As a leader in the PRP&HA regenerative field and as an innovation-driven company, Regen Lab SA has devoted important resources since 2004 to put on the market pioneering and diversified products constituting a complete set of tools/technologies for the medical community.